Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Long-Term Investments (2019 - 2025)

Historic Long-Term Investments for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to $410.3 million.

  • IDEAYA Biosciences' Long-Term Investments rose 110.02% to $410.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $410.3 million, marking a year-over-year increase of 110.02%. This contributed to the annual value of $410.3 million for FY2025, which is 110.02% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Long-Term Investments stood at $410.3 million for Q4 2025, which was up 110.02% from $350.0 million recorded in Q3 2025.
  • Over the past 5 years, IDEAYA Biosciences' Long-Term Investments peaked at $410.3 million during Q4 2025, and registered a low of $7.7 million during Q3 2022.
  • Over the past 5 years, IDEAYA Biosciences' median Long-Term Investments value was $114.4 million (recorded in 2021), while the average stood at $162.6 million.
  • Per our database at Business Quant, IDEAYA Biosciences' Long-Term Investments soared by 237598.71% in 2021 and then tumbled by 9365.52% in 2022.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Long-Term Investments stood at $121.3 million in 2021, then plummeted by 93.14% to $8.3 million in 2022, then skyrocketed by 1192.44% to $107.5 million in 2023, then surged by 277.55% to $405.8 million in 2024, then rose by 1.1% to $410.3 million in 2025.
  • Its Long-Term Investments stands at $410.3 million for Q4 2025, versus $350.0 million for Q3 2025 and $322.1 million for Q2 2025.